검색
Amgen Inc
AMGN관심 목록에 추가
403.200USD
+0.160+0.04%
시장 운영 시간 10/05, 14:00（ET）
217.61B시가총액
27.84P/E TTM
Amgen Inc 정보 회사
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.
Amgen Inc 프로필
종목 코드 AMGN
회사 이름Amgen Inc
상장일Jun 17, 1983
CEOBradway (Robert A)
직원 수28000
유형Ordinary Share
회계 연도 종료Jun 17
주소One Amgen Center Drive
도시THOUSAND OAKS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호91320-1799
전화18054471000
웹사이트https://www.amgen.com/
종목 코드 AMGN
상장일Jun 17, 1983
CEOBradway (Robert A)
Amgen Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Mr. Murdo Gordon
Mr. Murdo Gordon
Executive Vice President - Amgen Global Markets and Policy
Executive Vice President - Amgen Global Markets and Policy
48.67K
+1.91%
Mr. Derek Miller
Mr. Derek Miller
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.07K
--
Dr. Wanda M. Austin, Ph.D.
Dr. Wanda M. Austin, Ph.D.
Independent Director
Independent Director
8.02K
+8.29%
Ms. Nancy A. Grygiel
Ms. Nancy A. Grygiel
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
6.10K
--
Ms. Rachna Khosla
Ms. Rachna Khosla
Senior Vice President - Business Development
Senior Vice President - Business Development
5.93K
-33.70%
Dr. Tyler Jacks
Dr. Tyler Jacks
Independent Director
Independent Director
4.11K
+16.18%
Dr. Brian J. Druker, M.D.
Dr. Brian J. Druker, M.D.
Independent Director
Independent Director
3.82K
+17.39%
Dr. Mary E. Klotman
Dr. Mary E. Klotman
Independent Director
Independent Director
1.38K
+48.05%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Mr. Murdo Gordon
Mr. Murdo Gordon
Executive Vice President - Amgen Global Markets and Policy
Executive Vice President - Amgen Global Markets and Policy
48.67K
+1.91%
Mr. Derek Miller
Mr. Derek Miller
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.07K
--
Dr. Wanda M. Austin, Ph.D.
Dr. Wanda M. Austin, Ph.D.
Independent Director
Independent Director
8.02K
+8.29%
Ms. Nancy A. Grygiel
Ms. Nancy A. Grygiel
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
6.10K
--
자주 묻는 질문
Amgen Inc의 상위 5대 주주는 누구인가요?
Amgen Inc의 상위 5대 주주는 다음과 같습니다: Mr. Robert A. (Bob) Bradway
Amgen Inc(AMGN)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Amgen Inc의 주식을 보유한 기관은 총 4665곳이며, 이들이 보유한 주식의 총 가치는 약 460.83M로 전체 발행 주식의 85.38%를 차지합니다. 이는 2025Q4 대비 2252779.00 증가한 수치입니다.
Amgen Inc의 최대 수익원은 무엇인가요?
2026Q1 기준, Amgen Inc의 Other products 부문이 가장 높은 매출을 기록했으며, 금액은 1.70B로 전체 매출의 16.88%를 차지했습니다.